价格

A-33

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

HUMAN ANTI-IL-33 NEUTRALIZING MONOCLONAL ANTIBODY
EP 3088517 A1申请人: MITSUBISHI TANABE PHARMA CORP优先权: 2013
CN
EP
US
WO
13 件公开
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
EP 3092253 B1申请人: ANAPTYSBIO INC优先权: 2014
CN
EP
US
WO
10 件公开
METHODS OF TREATING INFLAMMATORY CONDITIONS
EP 3548513 A1申请人: REGENERON PHARMA优先权: 2016
CN
EP
US
WO
9 件公开
BIOMARKERS RELATED TO INTERLEUKIN-33 (IL-33)-MEDIATED DISEASES AND USES THEREOF
EP 3359567 A2申请人: REGENERON PHARMA优先权: 2015
CN
EP
US
WO
7 件公开
Anti-human interleukin-33 monoclonal antibody and use thereof
US 12351626 B2申请人: QYUNS THERAPEUTICS CO LTD优先权: 2021
CN
EP
US
WO
6 件公开
Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
- US 7198917 B2
  申请人: GENENTECH INC优先权: 2004
  US
  6 件公开
- US 7211400 B2
  申请人: GENENTECH INC优先权: 2001
  US
  5 件公开
- US 2010047772 A1
  申请人: ASHKENAZI AVI优先权: 2004
  US
  2 件公开
METHODS OF USING IL-33 ANTAGONISTS
EP 4054711 A1申请人: MEDIMMUNE LTD优先权: 2019
CN
EP
US
WO
5 件公开
ANTI-ST2 ANTIBODY AND APPLICATION THEREOF
EP 4095160 A4申请人: MABWELL SHANGHAI BIOSCIENCE CO LTD优先权: 2020
CN
EP
US
WO
5 件公开
IL-33 antagonist-containing therapeutic agent for endometriosis
US 11492398 B2申请人: MITSUBISHI TANABE PHARMA CORP优先权: 2017
CN
US
5 件公开
METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-33 ANTAGONIST
EP 3962515 A1申请人: SANOFI BIOTECHNOLOGY优先权: 2019
CN
EP
US
WO
4 件公开

药物

A-33

专利

Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens